ID   SCID5038D
AC   CVCL_E4C3
RX   PubMed=12738999;
CC   Characteristics: The parent cell line was injected subcutaneously into SCID mice and this cell line was established from tumors at the sites of innoculation (PubMed=12738999).
CC   Karyotypic information: Hypotetraploid karyotype (PubMed=12738999).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4C2 ! RC-9/E6E7
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
RX   PubMed=12738999; DOI=10.3892/ijo.22.6.1311;
RA   Ko D., Gu Y.-P., Yasunaga Y., Nakamura K., Srivastava S., Moul J.W.,
RA   Sesterhenn I.A., McLeod D.G., Arnstein P., Taylor D.O.N., Hukku B.,
RA   Rhim J.S.;
RT   "A novel neoplastic primary tumor-derived human prostate epithelial
RT   cell line.";
RL   Int. J. Oncol. 22:1311-1317(2003).
//